Breakthru Medicine

Private

Phoenix, ArizonaHealthcare & Life Scienceshttps://www.breakthrumed.com/

Last Round

Series A

Jan 29, 2026

Total Funding Raised

$60M

Company Overview

Breakthru Medicine is a biotechnology company developing oncology therapies for solid cancers using antibody-drug conjugates, small molecules, and molecular glues.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

oncology therapeuticsdrug discoveryprecision oncologysmall molecule therapeuticsantibody-drug conjugateADCmolecular glueprotein degradationtargeted therapybiotech startupdrug pipelinehard-to-drug targetspreclinical developmentbiopharmatherapeutic assets

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Breakthru Medicine Comparables

Compare Breakthru Medicine with similar companies based on industry and business-model similarity.

Breakthru Medicine comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Fortitude Biomedicines	87%
Nested Therapeutics	85%
Kivu Biosciences	83%

View all Comparables

Breakthru Medicine Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jan 29, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Steve Potts

CEO and Co-Founder

Founding Team

Breakthru Medicine Investors

Notable investors and investment history

Breakthru Medicine investors
Investor	Rounds
Eshelman Ventures	Series A, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 29, 2026
Company emerges from stealth with Series A financing.

View all signals

Breakthru Medicine Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Breakthru Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Breakthru Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhoenix, Arizona

Employee Range15

Year Founded2024

Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.